Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys® cortisol II assay: a pilot study
Abstract
Objectives
The glucagon stimulation test (GST) is used for the simultaneous assessment of central adrenal insufficiency (CAI) and growth hormone deficiency. The new Roche cortisol II (C II) assay was recently introduced, confounding interpretation of the GST. The performance of the GST in diagnosing central adrenal insufficiency (CAI), utilising the C II assay, was therefore compared with that of the overnight metyrapone test (ONMTPT).
Methods
A diagnostic accuracy study was performed by retrospectively analysing folders and laboratory records of 25 children and adolescents investigated for hypopituitarism with the GST and the ONMTPT between September 2016 and December 2019. The peak serum cortisol (C) of the GST, the post-metyrapone serum 11-deoxycortisol and adrenocorticotropin levels of the ONMTPT were recorded. Diagnostic performance of the GST at a previously suggested cut-off of 374 nmol/L was evaluated.
Results
Seventeen boys and 8 girls, aged 1.7–16.3 years (median 7.3 years) were identified. The sensitivity of the post-GST C-level at 374 nmol/L was 0.40 (95% confidence interval [CI] 0.17–0.69), specificity 0.64 (95% CI 0.39–0.84), positive predictive value 0.44 (95% CI 0.19–0.73), negative predictive value 0.60 (95% CI 0.36–0.80), accuracy 0.54 (95% CI 0.35–0.72), positive likelihood ratio (+LR) 0.93 (95% CI 0.49–1.77) and negative LR 1.12 (95% CI 0.40–3.15). The area under the receiver of operating characteristics (ROC) curve was 0.379 (95% CI 0.142–0.615).
Conclusions
This study suggests that the GST at any C II cut-off cannot replace the ONMTPT as a diagnostic test for CAI in children. Findings should be confirmed in a larger study.
Acknowledgments
The authors express their gratitude to all the registrars and medical officers who performed the tests as well as the laboratory staff who analysed the samples.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent for the overnight metyrapone test is routinely obtained from all parents/children admitted for this test.
-
Ethical approval: The research related to human use complied with all the relevant national regulations and institutional policies in accordance with the tenets of the Helsinki declaration. The study was approved by the Health Research Ethics Committee (HREC) of the Stellenbosch University (HREC number N21/03/031).
References
1. Böttner, A, Kratzsch, J, Liebermann, S, Keller, A, Pfäffle, RW, Kiess, W, et al.. Comparison of adrenal function tests in children – the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J Pediatr Endocrinol Metab 2005;18:433–42. https://doi.org/10.1515/jpem.2005.18.5.433.Suche in Google Scholar PubMed
2. Cegla, J, Jones, B, Seyani, L, Papadoulou, D, Wynne, K, Martin, NM, et al.. Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism. Clin Endocrinol 2013;78:738–42. https://doi.org/10.1111/cen.12043.Suche in Google Scholar PubMed
3. Zöllner, EW. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 1. Which test should be used? Pediatr Allergy Immunol 2007;18:401–9. https://doi.org/10.1111/j.1399-3038.2007.00540.x.Suche in Google Scholar PubMed
4. Leong, KS, Walker, AB, Martin, I, Wile, D, Wilding, J, MacFarlane, IA. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clin Endocrinol 2001;54:463–8. https://doi.org/10.1046/j.1365-2265.2001.01169.x.Suche in Google Scholar PubMed
5. Lim, SH, Vasanwala, R, Lek, N, Yap, F. Quantifying the risk of hypoglycaemia in children undergoing the glucagon stimulation test. Clin Endocrinol 2011;75:489–94. https://doi.org/10.1111/j.1365-2265.2011.04117.x.Suche in Google Scholar PubMed
6. Karaca, Z, Grossman, A, Kelestimur, F. Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis. Rev Endocr Metab Disord 2021;22:179–204. https://doi.org/10.1007/s11154-020-09611-3.Suche in Google Scholar PubMed
7. Di Iorgi, N, Napoli, F, Allegri, A, Secco, A, Calandra, E, Calcagno, A, et al.. The accuracy of the glucagon stimulation test in the diagnosis of adrenal insufficiency in young children with growth hormone deficiency. J Clin Endocrinol Metab 2010;95:2132–9. https://doi.org/10.1210/jc.2009-2697.Suche in Google Scholar PubMed
8. Raverot, V, Richet, C, Morel, Y, Raverot, G, Borson-Chazot, F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new roche diagnostics elecsys cortisol II assay. Ann Endocrinol 2016;77:620–2. https://doi.org/10.1016/j.ando.2016.05.002.Suche in Google Scholar PubMed
9. Kline, GA, Buse, J, Krause, RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem 2017;50:475–80. https://doi.org/10.1016/j.clinbiochem.2017.02.008.Suche in Google Scholar PubMed
10. Hawley, JM, Owen, LJ, Lockhart, SL, Monaghan, PJ, Armston, A, Chadwick, CA, et al.. Serum cortisol: an up-to-date assessment of routine assay performance. Clin Chem 2016;62:1220–9. https://doi.org/10.1373/clinchem.2016.255034.Suche in Google Scholar PubMed
11. Vogeser, M, Kratzsch, J, Bae, YJ, Bruegel, M, Ceglarek, U, Fiers, T, et al.. Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med 2017;55:826–35. https://doi.org/10.1515/cclm-2016-0400.Suche in Google Scholar PubMed
12. Grassi, G, Morelli, V, Cerlotti, F, Polledri, E, Fustinoni, S, D’Agostino, S, et al.. Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones 2020;19:425–31. https://doi.org/10.1007/s42000-020-00185-y.Suche in Google Scholar PubMed PubMed Central
13. Flück, CE. Assessing the function of the human adrenal cortex. In: Ranke, MB, Mullis, PE, editors. Diagnostics of endocrine function in children and adolescents. Basel: Karger; 2011:350–78 pp.10.1159/000327417Suche in Google Scholar
14. Zöllner, EW, Lombard, C, Galal, U, Hough, S, Irusen, E, Weinberg, E. Hypothalamicpiuitary-adrenal axis suppression in asthmatic school children. Pediatrics 2012;130:e1512–9. https://doi.org/10.1542/peds.2012-1147.Suche in Google Scholar PubMed
15. Ach, T, Yosra, H, Jihen, M, Asma, BA, Maha, K, Molka, C, et al.. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Endocr J 2018;65:935–42. https://doi.org/10.1507/endocrj.ej18-0147.Suche in Google Scholar PubMed
16. Berg, C, Meinel, T, Lahner, H, Yuece, A, Mann, K, Petersenn, S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol 2010;162:477–82. https://doi.org/10.1530/eje-09-0824.Suche in Google Scholar
17. Hamrahian, AH, Yuen, KCJ, Gordon, MB, Pulaski-Liebert, KJ, Benna, J, Biller, BMK. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of HG and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary 2016;19:332–41. https://doi.org/10.1007/s11102-016-0712-7.Suche in Google Scholar PubMed
18. El-Farhan, N, Rees, DA, Evans, C. Measuring cortisol in serum, urine and saliva – are our assays good enough? Ann Clin Biochem 2017;54:308–22. https://doi.org/10.1177/0004563216687335.Suche in Google Scholar PubMed
19. Littley, MD, Gibson, S, White, A, Shalet, SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol 1989;31:527–33. https://doi.org/10.1111/j.1365-2265.1989.tb01276.x.Suche in Google Scholar PubMed
20. Staub, JJ, Noelpp, B, Girard, J, Baumann, JB, Graf, RJG. The short metyrapone test: comparison of the plasma ACTH response to metyrapone and insulin-induced hypoglycaemia. Clin Endocrinol 1979;10:595–601. https://doi.org/10.1111/j.1365-2265.1979.tb02119.x.Suche in Google Scholar PubMed
Supplementary Material
The online version of this article offers the supplementary material (https://doi.org/10.1515/jpem-2022-0252).
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns
- Use of letrozole to augment height outcome in pubertal boys: a retrospective chart review
- Study of the frequency and clinical features of maturity-onset diabetes in the young in the pediatric and adolescent diabetes population in Iran
- Iatrogenic hyperthyroidism in primary congenital hypothyroidism: prevalence and predictive factors
- Utility of head CT scan in treatment decisions for suspected cerebral edema in children with DKA
- Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population
- Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys® cortisol II assay: a pilot study
- Effects and dose-response relationship of exercise training on cardiometabolic risk factors in children with obesity
- Biochemical indicators of euthyroid sick syndrome in critically ill children
- Short Communication
- Parental marital relationship satisfaction predicts glycemic outcomes in children with type 1 diabetes
- Case Reports
- Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism
- Three pediatric cases of symptomatic hyponatremia in Prader–Willi syndrome
- Identification of a novel mutation in FGFR1 gene in mother and daughter with Kallmann syndrome
- Exaggerated mini-puberty in a preterm girl: a case report and review of literature
- Diabetic ketoacidosis masquerading behind alkalemia an undiagnosed or missed variant of diabetic ketoacidosis
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns
- Use of letrozole to augment height outcome in pubertal boys: a retrospective chart review
- Study of the frequency and clinical features of maturity-onset diabetes in the young in the pediatric and adolescent diabetes population in Iran
- Iatrogenic hyperthyroidism in primary congenital hypothyroidism: prevalence and predictive factors
- Utility of head CT scan in treatment decisions for suspected cerebral edema in children with DKA
- Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population
- Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys® cortisol II assay: a pilot study
- Effects and dose-response relationship of exercise training on cardiometabolic risk factors in children with obesity
- Biochemical indicators of euthyroid sick syndrome in critically ill children
- Short Communication
- Parental marital relationship satisfaction predicts glycemic outcomes in children with type 1 diabetes
- Case Reports
- Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism
- Three pediatric cases of symptomatic hyponatremia in Prader–Willi syndrome
- Identification of a novel mutation in FGFR1 gene in mother and daughter with Kallmann syndrome
- Exaggerated mini-puberty in a preterm girl: a case report and review of literature
- Diabetic ketoacidosis masquerading behind alkalemia an undiagnosed or missed variant of diabetic ketoacidosis